Imagine a World Without AIDS

TO:

HEALTH, FAMILY EDITORS & NEWS ASSIGNMENT DESKS
 

WHAT:

Advocates for Youth and the AIDS Vaccine Advocacy Coalition will join together at the Washington, DC Johns Hopkins HIV vaccine clinic to discuss the implications of current HIV vaccine trials on those most at risk for HIV—young people, ages 15-24. The organizations will urge the scientific community to recognize the urgency of funding a vaccine that can be administered to young people before they become sexually active.

While young people make up 50% of all new HIV infections, more than 80% of HIV vaccine trial participants are adults ages 25-50. Fewer than 1% of participants are under age 18, yet 65% of young people in the United States are sexually active by that age.

Youth, youth leaders, and experts in the field will discuss why young people must be included in HIV vaccine trials and will call on vaccine trial sites to immediately increase their commitment to youth's participation. Medical experts will discuss current vaccine trials and the anticipated timing of FDA approval.

During the event, a vaccine trial participant will receive a vaccine injection and respond to questions about involvement in the trials.
 

WHEN:

Tuesday, December 5, 2000
10:00 to 11:00 AM ET
 

WHERE:

Center for Immunization Research, Johns Hopkins Vaccine Group
2112 F Street, NW, Suite 305
Washington, DC
 

WHO:

Mai Pham, Member, International Youth Leadership Council, Advocates for Youth
Emmie Henry, Member, International Youth Leadership Council, Advocates for Youth
Debra Hauser, MPH, Vice President, Advocates for Youth
Lawrence Miller, PhD, Executive Director, Black Educational AIDS Project
Board of Directors, AIDS Vaccine Advocacy Coalition
Rose McCullough, PhD, Executive Director, AIDS Vaccine Advocacy Coalition
David Mariner, Vaccine Trial Participant, Advocates for Youth